Protocol Ledger

NCT06963580 · Phase II · COMPLETED

Efficacy of MI078 Capsules in Treating Postpartum Depression

Interventional Phase II clinical trial protocol NCT06963580 sponsored by Nanjing Minova Pharmaceutical Co in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-09-09 Enrollment: 72 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06963580
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)72 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06963580
Protocol FieldVerified Registry Value
NCT IdentifierNCT06963580
Consolidated Lead SponsorNanjing Minova Pharmaceutical Co
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment72 participants (ACTUAL)
Registered Start Date2024-09-09
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06963580
Hospital Research SiteLocationSite Profile
The First Hospital of Hebei Medical UniversityShijiazhuang, ChinaOpen Hospital Dossier ->
The First Affiliated Hospital of Nanchang UniversityNanchang, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI